Age and sex do not explain territorial disparities in colorectal cancer screening
Abstract
Introduction: The Barcelona Colorectal Cancer Screening Program offers biennial Fecal Immunochemical Testing (FIT) to 400,000 residents aged 50–69. Analysis by Primary Healthcare Areas (PHAs) reveals territorial and temporal disparities in participation and positivity rates. These variations may stem from demographic structures, as both indicators vary by age and sex. This study aims to standardize these indicators to improve comparability across territories and evaluate the real influence of demographic variables on observed disparities.
Methods: Direct and indirect standardization methods were applied, using the program’s 7th round (2022–2023) as a reference. Standardized participation and FIT positivity rates were calculated for all PHAs across three consecutive biennial rounds (2018–2023).
Results: Directly standardized participation rates were higher in PHAs with younger populations and more men—groups with lower baseline uptake. However, the difference between crude and standardized rates did not exceed 1.7%, and significant territorial disparities persisted, with adjusted values ranging from 29% to 60%. Direct standardization also increased FIT positivity in younger, male-dominated areas, though the maximum increase was only 0.24 percentage points, with wide territorial variability remaining (2.8% to 6.8%). Through indirect standardization, we estimated expected participation between 47.3% and 50.2%, a much narrower range than observed rates. Expected positivity also showed minimal variation, oscillating between 4.05% and 4.2%.
Conclusions: The high similarity between crude and standardized rates indicates that territorial differences are not primarily driven by demographic structure, but likely stem from contextual factors and socioeconomic determinants.
Key messages: • Age and sex standardization does not explain the wide territorial gaps in screening participation, suggesting that demographic structure is not the primary driver of these health inequities.
• The persistence of disparities after adjustment indicates that socioeconomic and contextual factors, rather than population age or sex, are the main determinants of screening performance.
Related
- Why do colorectal and breast screening participation vary? A territorial mixed-method study, France
- Epigenetic Exposure Signatures Distinguish Early-Onset from Later-Onset Colorectal Cancer in a Racially Diverse US Cohort: Findings from the Disparities and Cancer Epidemiology (DANCE) Study
- Understanding cervical cancer screening disparities among Somali women in Southeast Minnesota: a community-engaged mixed methods study
- Toward Precision Colorectal Cancer Screening: Integrating Clinical Risk Stratification, Molecular Biomarkers, and Artificial Intelligence
- Twenty-Five Years of Colorectal Cancer Screening in the Czech Republic: National Registry Trends in Program Performance and Cancer Burden
BibTeX
@article{buron2026explain,
title = {{Age and sex do not explain territorial disparities in colorectal cancer screening}},
author = {A Buron and G Bosch and M Ferrer and J Sivilla and I Tora and J Grau and J M Auge and X Castells and M Sala},
journal = {The European Journal of Public Health},
year = {2026},
month = oct,
doi = {10.1093/eurpub/ckag169.1123},
url = {https://doi.org/10.1093/eurpub/ckag169.1123},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Age and sex do not explain territorial disparities in colorectal cancer screening
AU - A Buron
AU - G Bosch
AU - M Ferrer
AU - J Sivilla
AU - I Tora
AU - J Grau
AU - J M Auge
AU - X Castells
AU - M Sala
PY - 2026
DA - 2026/10/01
JO - The European Journal of Public Health
DO - 10.1093/eurpub/ckag169.1123
UR - https://doi.org/10.1093/eurpub/ckag169.1123
AB - Introduction: The Barcelona Colorectal Cancer Screening Program offers biennial Fecal Immunochemical Testing (FIT) to 400,000 residents aged 50–69. Analysis by Primary Healthcare Areas (PHAs) reveals territorial and temporal disparities in participation and positivity rates. These variations may stem from demographic structures, as both indicators vary by age and sex. This study aims to standardize these indicators to improve comparability across territories and evaluate the real influence of demographic variables on observed disparities. Methods: Direct and indirect standardization methods were applied, using the program’s 7th round (2022–2023) as a reference. Standardized participation and FIT positivity rates were calculated for all PHAs across three consecutive biennial rounds (2018–2023). Results: Directly standardized participation rates were higher in PHAs with younger populations and more men—groups with lower baseline uptake. However, the difference between crude and standardized rates did not exceed 1.7%, and significant territorial disparities persisted, with adjusted values ranging from 29% to 60%. Direct standardization also increased FIT positivity in younger, male-dominated areas, though the maximum increase was only 0.24 percentage points, with wide territorial variability remaining (2.8% to 6.8%). Through indirect standardization, we estimated expected participation between 47.3% and 50.2%, a much narrower range than observed rates. Expected positivity also showed minimal variation, oscillating between 4.05% and 4.2%. Conclusions: The high similarity between crude and standardized rates indicates that territorial differences are not primarily driven by demographic structure, but likely stem from contextual factors and socioeconomic determinants. Key messages: • Age and sex standardization does not explain the wide territorial gaps in screening participation, suggesting that demographic structure is not the primary driver of these health inequities. • The persistence of disparities after adjustment indicates that socioeconomic and contextual factors, rather than population age or sex, are the main determinants of screening performance.
SN - 1101-1262
SN - 1464-360X
ER -